GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
MicroStrategy (MSTR) Rebrands with New Name ‘Strategy’ Ahead of Earnings
Software company turned serial Bitcoin (BTC) acquirer MicroStrategy (MSTR) has unveiled a new name and logo hours before announcing its ...
Novo doubles down on next-gen weight loss therapy despite early setback
Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite ...
Why GSK Stock Is Surging Today
GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. GSK’s Beat-and-Raise Results ...
Le Lézard6h
Vaxxas Appoints Leading Global Vaccine Experts as the Company Advances its Needle-Free Vaccination Technology Towards Late-Stage Clinical Trials
Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...
LIVE: Wall Street heads lower as Trump trade war fears offset US payroll growth
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term Outlook
GSK reports better-than-expected Q4 earnings. It also announces a new share buyback program and raises the long-term sales outlook for 2031 by $2 billion.
GSK raises long-term guidance, announces buybacks
GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected earnings for Q4 2025.
Alstom S.A.: Alstom and KNDS have reached agreement: a secure future for the industrial site in Görlitz in Germany
Sustainable prospects for the majority of staff at the siteFirst staff takeovers and start of production at KNDS already planned for 2025 5 February, 2025 - The negotiations between Alstom and KNDS De ...
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead ...
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...
SA Asks: Which Big Pharmas would be most impacted by higher tariffs?
Which Big Pharmas would be most impacted by higher tariffs? Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader weigh in. Read more here.